Početna › Bolesti pluća › Tennessee
Kliničke studije za Bolesti pluća u državi Tennessee
15 studija za Bolesti pluća traži sudionike na lokacijama u državi Tennessee.
Gradovi u državi Tennessee
Službeni tekst studije (engleski)
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- SCRI Oncology Partners, Nashville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06765109A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- WR-Clinsearch, LLC, Chattanooga
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06679140Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- University of Tennessee Medical Center, Knoxville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07489066A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- West Tennessee Research Institute, Jackson
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07013474American Lung Association (ALA) Lung Health Cohort
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 25 do 35 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT04543461Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Sarah Cannon Research Institue, Nashville
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06128551A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Premier Research Center, LLC, Hendersonville
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Tennessee Oncology Chattanooga, Chattanooga
- University of Tennessee Medical Center, Knoxville
- Baptist Memorial Hospital-Memphis, Memphis
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 2
Od 40 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07059091Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Trials Center of Middle Tennesee LLC, Franklin
U tijeku regrutacijaFaza 3
Od 40 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07284602A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- SCRI Oncology Partners, Nashville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT05967689Cooperative Assessment of Late Effects for SCD Curative Therapies
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaOpažajna studija
Od 4 do 65 godina · Oba spola · Ažurirano 27. srp 2026. · NCT05153967Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of Tennessee Medical Center, Knoxville
- Baptist Cancer Center, Memphis
U tijeku regrutacijaFaza 2
Od 18 do 70 godina · Oba spola · Ažurirano 26. lip 2026. · NCT04614103A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Tristar Bone Marrow Transplant, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. pro 2025. · NCT06619561Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.